CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-04 | Payne Fletcher Chief Financial Officer | Exercise or conversion | +1,503 | $4.63 | $7K | 3,230 |
| 2019-02-04 | Payne Fletcher Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,503 | 73,497 | ||
| 2019-01-31 | Levy Howard Chief Medical Officer | Exercise or conversion | +1,500 | $4.63 | $7K | 9,382 |
| 2019-01-31 | Levy Howard Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 93,500 | ||
| 2019-01-31 | USMAN NASSIM President & CEO | Exercise or conversion | +5,729 | $4.63 | $27K | 11,041 |
| 2019-01-31 | USMAN NASSIM President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −5,729 | 269,271 | ||
| 2019-01-24 | USMAN NASSIM President and CEO | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2019-01-24 | Payne Fletcher Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2019-01-24 | Levy Howard Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-12-31 | Williams Eddie Director | Grant or award | +1,544 | 1,672 | ||
| 2018-12-31 | LAWLOR AUGUSTINE Director | Grant or award | +2,732 | 2,732 | ||
| 2018-12-31 | Hunt Andrea Director | Grant or award | +811 | 811 | ||
| 2018-12-31 | DESOUZA ERROL B Director | Grant or award | +1,703 | 1,944 | ||
| 2018-11-26 | Levy Howard Chief Medical Officer | Exercise or conversion | +149 | $4.63 | $690 | 7,709 |
| 2018-11-26 | Levy Howard Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −149 | 87,118 | ||
| 2018-11-16 | Levy Howard Chief Medical Officer | Exercise or conversion | +173 | $4.63 | $801 | 7,733 |
| 2018-11-16 | Levy Howard Chief Medical Officer | Sale | −173 | $11.00 | $2K | 7,560 |
| 2018-11-16 | Levy Howard Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −173 | 87,267 | ||
| 2018-09-06 | HILL STEPHEN A Director | Returned to the company | −190 | $10.07 | $2K | 1,190 |
| 2018-07-30 | USMAN NASSIM President & CEO | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 19 of 24 · 471 trades